Session

New horizons in LUTS

Poster Session 22

  • Location:
    Room Madrid (Hall B2, level 0)
  • Chairs:
     F. Cruz, Porto (PT)
     M.J. Drake, Bristol (GB)
     A. Ruffion, Pierre-Bénite (FR)
  • Aims and objectives of this session

    Recent advances in the area of bladder pathophysiology, pharmacology and stem cell therapy will be presented and discussed

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
* 271
Sphingosine-1-phosphate, a new biomarker of detrusor overactivity in patients with multiple sclerosis

By: Sanson S.1, Roumiguié M.1, Ballouhey Q.2, Castel-Lacanal E.3, Jaafar A.4, Tack Y.4, Game X.1

Institutes: 1CHU Rangueil, Dept. of Urology, Toulouse, France, 2CHU, Dept. of Pediatric Surgery, Limoges, France, 3CHU Rangueil, Dept. of Physical Medicine and Rehabilitation, Toulouse, France, 4CHU Rangueil, Dept. of Physiological Functional Exploration, Toulouse, France

272
Differences in organisation and phenotypes of interstitial cells in bladder lamina propria between human and laboratory animals

By: Gevaert T.1, Steiner C.2, Vanstreels E.3, Pintelon I.4, Timmermans J-P.4, Neuhaus J.2, De Ridder D.1

Institutes: 1UZ Leuven, Dept. of Urology, Leuven, Belgium, 2University of Leipzig, Dept. of Urology, Leipzig, Germany, 3KU Leuven, Dept. of Laboratory of Virology and Chemotherapy (Rega Institute), Leuven, Belgium, 4University of Antwerp, Dept. of Veterinary Sciences, Antwerp, Belgium

* 273
Altered muscarinic signalling in the urinary bladder of mouse models of Alzheimer’s disease

By: Hohnen R.1, Zare A.1, Stevens J.1, Losen M.1, Meriaux C.1, Rahnama’i M.S.2, Van Koeveringe G.2

Institutes: 1Maastricht University, Dept. of Neuroscience, Maastricht, The Netherlands, 2Maastricht University Medical Centre, Dept. of Urology, Maastricht, The Netherlands

274
Measurement of endocannabinoids levels during treatment of bladder hyperactivity induced by cystitis with FAAH inhibitors and evaluation of the cannabinoid receptor and TRPV1 roles

By: Charrua A.1, Matos R.1, Marczylo T.2, Nagy I.3, Cruz F.1

Institutes: 1Faculty of Medicine of University of Porto, Dept. of Experimental Biology, Porto, Portugal, 2Public Health England, Chilton, United Kingdom, 3Faculty of Medicine, Imperial College of London, Dept. of Surgery & Cancer, London, United Kingdom

275
Up-regulation of prostatic cannabinoid receptor type 2 following capsaicin-induced prostatitis in castrated and non-castrated rats

By: Lin T.L.

Institutes: National Yang-Ming University Taipei Veterans Gen Hospital, Dept. of Urology, Taipei, Taiwan

276
Does TRP channel play a role of extracellular calcium sensing in urethral smooth muscle?

By: Kajioka S., Hayashi M., Maki T., Takahashi R., Etoh M.

Institutes: Kyushu University, Dept. of Urology, Fukuoka, Japan

277
Mouse model with ketamine-induced voiding dysfunction demonstrates intact urothelial barrier function

By: Rajandram R.1, Ong T.A.1, Razack A.1, Maciver I.B.2, Zeidel M.2, Yu W.2

Institutes: 1University of Malaya, Dept. of Surgery, Kuala Lumpur, Malaysia, 2Beth Israel Deaconess Medical Center and Harvard Medical School, Dept. of Medicine, Boston, United States of America

278
Safety and effectiveness of mirabegron in patients with overactive bladder (OAB): Results of two Japanese post-marketing surveys

By: Kato D.1, Katoh T.2, Kuwamoto K.1, Nozawa Y.1, Tabuchi H.1, Kuroishi K.1

Institutes: 1Astellas Pharma Inc, Medical Affairs, Tokyo, Japan, 2International University of Health and Welfare, Mita Hospital, Cardiovascular Centre, Tokyo, Japan

279
Bladder acellular matrix grafts seeded with adipose-derived stem cells and incubated intraperitoneally promote the regeneration of bladder smooth muscle in a rat model of bladder augmentation

By: Zhou Z.2, Da J.2, Zhao Y.2, Zhang M.2, Xiao D.2, Wang Q.2, Wang Z.2, Lu M.1

Institutes: 1Shanghai 9th People’s Hospital, Shanghai, China, 2Shanghai 9th People’s Hospital, Dept. of Urology, Shanghai, China

280
Advanced properties of urine derived stem cells compared to adipose tissue derived stem cells in terms of cell proliferation, immune modulation and multi differentiation

By: Choi S.H.1, Chung J-W.1, Lee J.N.1, Ha Y-S.1, Kim B.S.1, Kim H.T.1, Kim T-H.1, Yoo E.S.1, Kwon T.G.1, Chung S.K.1, Kim B.W.1, Cho D-H.2, Kim J.S.3

Institutes: 1Kyungpook University Hospital, Dept. of Urology, Daegu, South Korea, 2CHA Gumi Medical Center, Dept. of Urology, Gumi-Si, South Korea, 3Daegu Fatima Hospital, Dept. of Urology, Daegu, South Korea

281
Functional smooth muscle cells differentiated from adipose derived stem cells: The importance of authophagy

By: Salemi S., Mortezavi A., Sulser T., Eberli D.

Institutes: University Hospital Zürich, Dept. of Urology, Zurich, Switzerland

Summary and context
 F. Cruz, Porto (PT)